Zika virus: A new challenge for blood transfusion

The Lancet

Volumn 387, Issue 10032, 2016, Pages 1993-1994

  Musso, Didier ^a   Stramer, Susan L ^b   Busch, Michael P ^c  

^a INSTITUT LOUIS MALARDÉ   (French Polynesia)

^b AMERICAN RED CROSS   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

BLOOD DONOR; BLOOD TRANSFUSION; BLOOD VOLUME; DISEASE TRANSMISSION; FLAVIVIRUS; HUMAN; INFECTION RISK; LETTER; NEUROLOGICAL COMPLICATION; PATIENT SAFETY; PLASMA; PRIORITY JOURNAL; RECIPIENT; THROMBOCYTE; WEST NILE VIRUS; ZIKA VIRUS; ADVERSE EFFECTS; DONOR SELECTION; PREVENTION AND CONTROL; TRANSMISSION; ZIKA FEVER;

BLOOD TRANSFUSION; DONOR SELECTION; HUMANS; ZIKA VIRUS INFECTION;

EID: 84964787390     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)30428-7     Document Type: Letter

References (5)

1. D Musso, DJ Gubler Zika virus Clin Microbiol Rev 29 2016 487 524
2. SL Stramer, FB Hollinger, LM Katz et al. Emerging infectious disease agents and their potential threat to transfusion safety Transfusion 49 suppl 2 2009 S1 29
3. RY Dodd, GA Foster, SL Stramer Keeping blood transfusion safe from West Nile virus: American Red Cross Experience, 2003 to 2012 Transfus Med Rev 29 2015 153 161
4. US Food and Drug Administration Recommendations for donor screening, deferral, and product management to reduce the risk of transfusion-transmission of Zika virus guidance for industry http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM486360.pdf February, 2016 (accessed April 25, 2016).
5. WHO Maintaining a safe and adequate blood supply during Zika virus outbreaks. Interim guidance http://apps.who.int/iris/bitstream/10665/204436/1/WHO-ZIKV-HS-16.1-eng.pdf?ua=1 February, 2016 (accessed April 25, 2016).